These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 24730513)
1. Biomarker-based calibration of retrospective exposure predictions of perfluorooctanoic acid. Shin HM; Steenland K; Ryan PB; Vieira VM; Bartell SM Environ Sci Technol; 2014 May; 48(10):5636-42. PubMed ID: 24730513 [TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations. Worley RR; Yang X; Fisher J Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146 [TBL] [Abstract][Full Text] [Related]
3. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community. Seals R; Bartell SM; Steenland K Environ Health Perspect; 2011 Jan; 119(1):119-24. PubMed ID: 20870569 [TBL] [Abstract][Full Text] [Related]
4. Polyfluoroalkyl substance exposure in the Mid-Ohio River Valley, 1991-2012. Herrick RL; Buckholz J; Biro FM; Calafat AM; Ye X; Xie C; Pinney SM Environ Pollut; 2017 Sep; 228():50-60. PubMed ID: 28505513 [TBL] [Abstract][Full Text] [Related]
5. A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes. Dhingra R; Winquist A; Darrow LA; Klein M; Steenland K Environ Health Perspect; 2017 Mar; 125(3):416-421. PubMed ID: 27529882 [TBL] [Abstract][Full Text] [Related]
6. Perfluorooctanoic acid and chronic kidney disease: Longitudinal analysis of a Mid-Ohio Valley community. Dhingra R; Lally C; Darrow LA; Klein M; Winquist A; Steenland K Environ Res; 2016 Feb; 145():85-92. PubMed ID: 26656498 [TBL] [Abstract][Full Text] [Related]
7. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Shin HM; Vieira VM; Ryan PB; Steenland K; Bartell SM Environ Health Perspect; 2011 Dec; 119(12):1760-5. PubMed ID: 21813367 [TBL] [Abstract][Full Text] [Related]
8. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers. Winquist A; Lally C; Shin HM; Steenland K Environ Health Perspect; 2013 Aug; 121(8):893-9. PubMed ID: 23735518 [TBL] [Abstract][Full Text] [Related]
9. Retrospective exposure reconstruction using approximate Bayesian computation: A case study on perfluorooctanoic acid and preeclampsia. Zhu Y; Shin HM; Jiang L; Bartell SM Environ Res; 2022 Jun; 209():112892. PubMed ID: 35149111 [TBL] [Abstract][Full Text] [Related]
10. Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility. Hoffman K; Webster TF; Bartell SM; Weisskopf MG; Fletcher T; Vieira VM Environ Health Perspect; 2011 Jan; 119(1):92-7. PubMed ID: 20920951 [TBL] [Abstract][Full Text] [Related]
11. Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community. Darrow LA; Groth AC; Winquist A; Shin HM; Bartell SM; Steenland K Environ Health Perspect; 2016 Aug; 124(8):1227-33. PubMed ID: 26978841 [TBL] [Abstract][Full Text] [Related]
12. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Steenland K; Zhao L; Winquist A; Parks C Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465 [TBL] [Abstract][Full Text] [Related]
13. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Barry V; Winquist A; Steenland K Environ Health Perspect; 2013; 121(11-12):1313-8. PubMed ID: 24007715 [TBL] [Abstract][Full Text] [Related]
14. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure. Barry V; Darrow LA; Klein M; Winquist A; Steenland K Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729 [TBL] [Abstract][Full Text] [Related]
15. Perfluorooctanoic acid exposure and natural menopause: A longitudinal study in a community cohort. Dhingra R; Darrow LA; Klein M; Winquist A; Steenland K Environ Res; 2016 Apr; 146():323-30. PubMed ID: 26802619 [TBL] [Abstract][Full Text] [Related]
16. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Winquist A; Steenland K Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430 [TBL] [Abstract][Full Text] [Related]
17. Perfluorooctanoate exposure and major birth defects. Stein CR; Savitz DA; Elston B; Thorpe PG; Gilboa SM Reprod Toxicol; 2014 Aug; 47():15-20. PubMed ID: 24803403 [TBL] [Abstract][Full Text] [Related]
18. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Bartell SM; Calafat AM; Lyu C; Kato K; Ryan PB; Steenland K Environ Health Perspect; 2010 Feb; 118(2):222-8. PubMed ID: 20123620 [TBL] [Abstract][Full Text] [Related]
19. Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population. Avanasi R; Shin HM; Vieira VM; Bartell SM Environ Res; 2016 Apr; 146():299-307. PubMed ID: 26796985 [TBL] [Abstract][Full Text] [Related]
20. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Savitz DA; Stein CR; Bartell SM; Elston B; Gong J; Shin HM; Wellenius GA Epidemiology; 2012 May; 23(3):386-92. PubMed ID: 22370857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]